3 2020 Annual Global Symposium on GCR - Survey

Conference, Meeting, Workshop, and Poster Session Registration Generic Clearance (OD)

2020 Annual Global Symposium on GCR - Survey

The 8th Annual Global Cancer Research Symposium (NCI)

OMB: 0925-0740

Document [docx]
Download: docx | pdf

Shape1

OMB No.: 0925-0740

Expiration Date: 07/31/2022

Public reporting burden for this collection of information is estimated to average 10 minutes per response, including the time for reviewing instructions, searching existing data sources, gathering and maintaining the data needed, and completing and reviewing the collection of information. An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB control number. Send comments regarding this burden estimate or any other aspect of this collection of information, including suggestions for reducing this burden to: NIH, Project Clearance Branch, 6705 Rockledge Drive, MSC 7974, Bethesda, MD 20892-7974, ATTN: PRA (0925-0740). Do not return the completed form to this address.















8Th Annual Symposium on Global Cancer Research: Participant Satisfaction Survey

Thank you for your participation in the 8th Annual Symposium on Global Cancer Research, “Creative approaches to global cancer research and control”. The organizing committee would like to get an understanding if we achieved our core objectives and ideas for improvements for the future. The objectives of this full-day Symposium on Global Cancer Research were to: (1) provide a venue for the global oncology research community to exchange information to identify potential areas for collaboration; (2) engage in interactive discussion about the findings and potential implications of the 2018-2019 Global Oncology Survey of NCI-Designated Cancer Centers for the global oncology community; (3) develop a set of strategic priorities for advancing the field of global oncology in both low and high resource settings – with a focus on topics such as research priorities to address the full spectrum of cancer disparities, training needs, mentorship and capacity building, institutional leadership, and access to resources (infrastructure, human, financial); and (4) share initiatives that are reducing the burden of cancer in low resource settings. This survey should take approximately 5-10 minutes of your time.



Thank you,

ASGCR 2020 Organizing Committee



*1. What is your level of experience?

  • Undergraduate Student

  • Graduate or Medical Student

  • Post-doc or Resident

  • Junior-level Faculty/Professional

  • Mid-level Faculty/Professional

  • Senior-level Faculty/Professional



*2. What is your specific area of work and/or interest: cancer sites? Please select as many as apply.

  • Non Site-Specific cancer

  • Anal cancer

  • Bladder cancer

  • Blood cancer

  • Bone cancer

  • Brain tumor and nervous system

  • Breast cancer

  • Cervical cancer

  • Colorectal cancer

  • Endometrial cancer

  • Esophageal cancer

  • Gallbladder cancer

  • Gastrointestinal tract

  • Head and Neck cancer

  • Heart cancer

  • Hodgkin’s disease

  • Kaposi’s sarcoma

  • Kidney cancer

  • Laryngeal cancer

  • Leukemia

  • Liver cancer

  • Lung cancer

  • Melanoma or skin cancer

  • Myeloma

  • Nasal Cavity

  • Neuroblastoma

  • Non-Hodgkin’s lymphoma

  • Oral Cavity and Lip cancer

  • Pancreatic cancer

  • Penile cancer

  • Prostate cancer

  • Retinoblastoma

  • Sarcoma

  • Stomach cancer

  • Testicular cancer

  • Thyroid cancer

  • Urinary system

  • Vascular system

  • Other, please specify here: ____________________________________



*3. What is your specific area of work and/or interest: cancer research and control areas? Please select as many as apply.

  • Biology

  • Etiology

  • Prevention

  • Early Detection

  • Diagnosis and Staging

  • Treatment

  • Survivorship

  • Palliative Care

  • Cancer Control

  • Other, please specify here: ___________________________



*4. What country setting(s) do you work in? Please select as many as apply.

  • High-income countries

  • Low- or middle-income countries



*5. To what extent do you agree or disagree with the following statements about your overall experience at the Symposium?


Completely Agree

Agree

Disagree

Completely Disagree

I was satisfied with the content of the symposium

The symposium content was useful to my work/interests

My knowledge on creative approaches to global cancer research and control was advanced or complemented by the symposium

The symposium provided an opportunity for information exchange among participants

I was able to make connections with other participants at the symposium

The symposium working groups offered me opportunities to contribute to building communities of practice for the global oncology community

I understand how I can continue to participate in symposium working groups/communities of practice over the course of the following year, if I am interested.



Shape2 *6. What was most valuable about the Symposium?



*7. For each of the following Symposium sessions, please rate their usefulness to you as a participant and provide any feedback for improvement of the session, including comments on content and/or format.


Very Useful

Moderately Useful

Slightly Useful

Not Useful

Did Not Attend

Welcome Session

Feedback for session improvement:


Panel #1

Feedback for session improvement:


Panel #2

Feedback for session improvement:


Working Session #1

Feedback for session improvement:


Working Session #2

Feedback for session improvement:


Rapid Fire Abstract Session

Feedback for session improvement:


Conference Posters Session/Networking Lunch

Feedback for session improvement:


Keynote Session: Pearline Award Winner

Feedback for session improvement:




*8. To what extent do you believe that the 8th Annual Symposium on Global Cancer Research was able to achieve the following objectives?


Completely Achieved

Partially Achieved

Marginally Achieved

Not at All Achieved

Provide a venue for the global oncology research community to exchange information to identify potential areas for collaboration.

Engage in interactive discussion about the findings and potential implications of the 2018-2019 Global Oncology Survey of NCI-Designated Cancer Centers for the global oncology community.

Develop a set of strategic priorities for advancing the field of global oncology in both low and high resource settings – with a focus on topics such as research priorities to address the full spectrum of cancer disparities, training needs, mentorship and capacity building, institutional leadership, and access to resources (infrastructure, human, financial).

Share initiatives that are reducing the burden of cancer in low resource settings.



Shape3 9. If you do not believe the Symposium was able to achieve some of its objectives, please use the space below to briefly explain why and provide feedback.



*10. To what extent were you satisfied with the following elements of the Symposium organization and format?


Very Satisfied

Somewhat Satisfied

Neutral

Not Satisfied

N/A

Clarify of meeting objectives

Online registration process

Check-in on the day of the Symposium

Symposium venue

Quality of material circulated by the organizers

Organization of the agenda

Quality of presentations

Abstract Submission Process (if applicable)



Shape4 11. Please use the space below to provide any recommendations to improve the organization and/or format of the Symposium.



Shape5 12. Please use the space below to indicate any discussion topics that you would like addressed at next year’s Symposium.



Shape6 13. Please use the space below to provide any additional comments or recommendations for improving future Symposia?





The 9th Symposium on Global Cancer Research will be held in Houston, Texas, in Spring of 2021. Are you likely to:

*14. Recommend the meeting to others?

  • Yes

  • No

*15. Attend?

  • Yes

  • No

16. Volunteer to be part of the planning committee?

  • Yes

  • No

Shape7 If “yes”, please send an email to ____________________ or enter your email address here:



Thank you for your participation.

File Typeapplication/vnd.openxmlformats-officedocument.wordprocessingml.document
AuthorAbudu, Rachel (NIH/NCI) [C]
File Modified0000-00-00
File Created2021-01-15

© 2024 OMB.report | Privacy Policy